• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种不同方法监测抗高血压治疗期间不良反应的比较。

Comparison of three different methods of monitoring unwanted effects during antihypertensive therapy.

作者信息

Borghi C, Pallavini G, Comi D, Grillo G, Lombardo M, Mantero O, Minetti L, Selvini A, Suppa G

出版信息

Int J Clin Pharmacol Ther Toxicol. 1984 Jun;22(6):324-8.

PMID:6378807
Abstract

In a double-blind, randomized, crossover, multicenter study performed in 227 hypertensive outpatients, two antihypertensive drugs, oxprenolol and chlorthalidone, were investigated to determine unwanted effects. Three main methodologic procedures were applied: the conventional evaluation of unwanted effects by the physician and involving the whole patient population, the checklist, and the free questionnaire. The latter two were assigned by randomization to the patients themselves. The study showed that unwanted effects seem to be frequently overreported when a checklist is used, whereas the free questionnaire gives more information about the symptoms of the disease than about the tolerance of the drug. The conventional method, when physicians are well-informed and sensitized to the problem, seems to provide more reliable information about unwanted effects of a drug.

摘要

在一项针对227名高血压门诊患者开展的双盲、随机、交叉、多中心研究中,对两种抗高血压药物氧烯洛尔和氯噻酮进行了研究,以确定其不良反应。采用了三种主要的方法学程序:医生对全体患者进行常规不良反应评估、使用清单法以及自由问卷法。后两种方法通过随机分配给患者本人。研究表明,使用清单法时,不良反应似乎经常被过度报告,而自由问卷法提供的关于疾病症状的信息比关于药物耐受性的信息更多。当医生充分了解并对该问题敏感时,传统方法似乎能提供关于药物不良反应更可靠的信息。

相似文献

1
Comparison of three different methods of monitoring unwanted effects during antihypertensive therapy.三种不同方法监测抗高血压治疗期间不良反应的比较。
Int J Clin Pharmacol Ther Toxicol. 1984 Jun;22(6):324-8.
2
[Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
Clin Ter. 1981 Apr 15;97(1):63-9.
3
Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.氧烯洛尔与氢氯噻嗪固定组合治疗轻至中度动脉高血压的降压活性
Int J Clin Pharmacol Ther Toxicol. 1980;18(8):332-7.
4
Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
Int J Clin Pharmacol Res. 1983;3(3):153-6.
5
Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.非洛地平与氯噻酮治疗原发性高血压的双盲交叉研究。
Int J Clin Pharmacol Ther Toxicol. 1985 Sep;23(9):501-5.
6
[Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
Arq Bras Cardiol. 1980 May;34(5):409-14.
7
Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
G Ital Cardiol. 1980;10(4):476-9.
8
Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
Pharmatherapeutica. 1982;3(3):153-6.
9
Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.给药时间对原发性高血压患者中氯噻酮的降压及低钾血症作用的影响。
Int J Clin Pharmacol Res. 1985;5(2):109-12.
10
Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.卡托普利和氧烯洛尔与噻嗪类利尿剂的固定复方制剂:降压疗效和代谢效应的比较
Clin Ther. 1984;6(5):708-18.

引用本文的文献

1
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
2
The way towards adverse event monitoring in clinical trials.临床试验中不良事件监测的方法。
Drug Saf. 1993 Mar;8(3):251-62. doi: 10.2165/00002018-199308030-00006.
3
Intraindividual comparison of moxonidine and prazosin in hypertensive patients.
Eur J Clin Pharmacol. 1986;29(6):645-50. doi: 10.1007/BF00615953.
4
Evaluation of three methods of symptom reporting in a clinical trial of felodipine.在非洛地平临床试验中三种症状报告方法的评估。
Eur J Clin Pharmacol. 1991;41(3):187-96. doi: 10.1007/BF00315428.